Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1474-14-2

(2S)-2-[(3S,8S,9S,10R,13S,14S,17R)-3-(acetyloxy)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]propanoic acid (non-preferred name) is a complex steroidal molecule characterized by a cyclopenta[a]phenanthrene backbone and a propanoic acid side chain. It features multiple methyl groups and an acetyloxy group, which is derived from acetic acid. This molecule is a steroid derivative with potential pharmaceutical applications, particularly in hormone therapy. The non-preferred name suggests that it may not be widely recognized within the scientific community, and a more standardized nomenclature could facilitate clearer communication.

1474-14-2 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

  • (2S)-2-[(3S,8S,9S,10R,13S,14S,17R)-3-(acetyloxy)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]propanoic acid (non-preferred name)

    Cas No: 1474-14-2

  • USD $ 10.0-10.0 / Milligram

  • 1 Milligram

  • 100000000 Kilogram/Month

  • weifang yangxu group co.,ltd
  • Contact Supplier

  • (2S)-2-[(3S,8S,9S,10R,13S,14S,17R)-3-(acetyloxy)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]propanoic acid (non-preferred name)

    Cas No: 1474-14-2

  • USD $ 2.0-2.0 / Kilogram

  • 1 Kilogram

  • 10000000 Kilogram/Year

  • TAIZHOU ZHENYU BIOTECHNOLOGY CO., LTD
  • Contact Supplier

  • (2S)-2-[(3S,8S,9S,10R,13S,14S,17R)-3-(acetyloxy)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]propanoic acid (non-preferred name)

    Cas No: 1474-14-2

  • No Data

  • No Data

  • No Data

  • Xi`an Eastling Biotech Co., Ltd.
  • Contact Supplier

  • (2S)-2-[(3S,8S,9S,10R,13S,14S,17R)-3-(acetyloxy)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]propanoic acid (non-preferred name)

    Cas No: 1474-14-2

  • No Data

  • No Data

  • No Data

  • Shandong Mopai Biotechnology Co., LTD
  • Contact Supplier
  • 1474-14-2 Structure

  • Basic information

    1. Product Name: (2S)-2-[(3S,8S,9S,10R,13S,14S,17R)-3-(acetyloxy)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]propanoic acid (non-preferred name)
    2. Synonyms: Pregn-5-ene-20-carboxylic acid, 3- (acetyloxy)-, (3.beta.,20S)-
    3. CAS NO:1474-14-2
    4. Molecular Formula: C24H36O4
    5. Molecular Weight: 388.5402
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 1474-14-2.mol

  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 506.8°C at 760 mmHg
    3. Flash Point: 166.4°C
    4. Appearance: N/A
    5. Density: 1.13g/cm3
    6. Vapor Pressure: 1.21E-11mmHg at 25°C
    7. Refractive Index: 1.544
    8. Storage Temp.: N/A
    9. Solubility: N/A
    10. CAS DataBase Reference: (2S)-2-[(3S,8S,9S,10R,13S,14S,17R)-3-(acetyloxy)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]propanoic acid (non-preferred name)(CAS DataBase Reference)
    11. NIST Chemistry Reference: (2S)-2-[(3S,8S,9S,10R,13S,14S,17R)-3-(acetyloxy)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]propanoic acid (non-preferred name)(1474-14-2)
    12. EPA Substance Registry System: (2S)-2-[(3S,8S,9S,10R,13S,14S,17R)-3-(acetyloxy)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]propanoic acid (non-preferred name)(1474-14-2)

  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 1474-14-2(Hazardous Substances Data)

1474-14-2 Usage

Uses

Used in Pharmaceutical Industry:
(2S)-2-[(3S,8S,9S,10R,13S,14S,17R)-3-(acetyloxy)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]propanoic acid (non-preferred name) is used as a pharmaceutical agent for hormone therapy due to its steroidal structure and potential to modulate hormonal activity.
Used in Drug Development Research:
This molecule is utilized in drug development research to explore its potential as a therapeutic agent for various conditions that may benefit from hormone regulation or modulation. Its unique structure and functional groups make it a candidate for further investigation into its pharmacological properties and efficacy.

Check Digit Verification of cas no

The CAS Registry Mumber 1474-14-2 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,4,7 and 4 respectively; the second part has 2 digits, 1 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 1474-14:
(6*1)+(5*4)+(4*7)+(3*4)+(2*1)+(1*4)=72
72 % 10 = 2
So 1474-14-2 is a valid CAS Registry Number.

1474-14-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name (2S)-2-[(3S,8S,9S,10R,13S,14S,17R)-3-acetyloxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]propanoic acid

1.2 Other means of identification

Product number -
Other names perfluorobutyl ether

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1474-14-2 SDS

1474-14-2Downstream Products

1474-14-2Relevant articles and documents

NEUROACTIVE STEROIDS, COMPOSITIONS, AND USES THEREOF

-

, (2016/02/16)

Provided are methods of evaluating or treating a patient, e.g., a patient having a disorder described herein, comprising: a) optionally, acquiring a patient sample; b) acquiring an evaluation of and/or evaluating the sample for an alteration in the level S24(S)-hydroxycholesterol compared to a reference standard.

NEUROACTIVE STEROIDS, COMPOSITIONS, AND USES THEREOF

-

, (2013/03/26)

Compounds are provided according to Formula (I) and pharmaceutically acceptable salts thereof, wherein Z is a group of the formula (i), (ii), (iii), (iv), or (v), and wherein L1, L2, L3, X1, X2, Y, Rz4, Rz5, Rz6, n, R1, R2, R3a, R3b, R4a, R4b, R6a, R6b, R7a, R7b, R11a, R11b, R14, R17, R19, R20, R23a, R23b, and R24 are as defined herein, and pharmaceutical compositions thereof. Compounds of the present invention are contemplated useful for the prevention and treatment of a variety of CNS-related conditions in mammals.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1474-14-2